Researchmoz.us announces that a new market research report is available in its catalogue: Global and China Monoclonal Antibody Industry Report, 2013
In recent years, the monoclonal antibody market around the globe has witnessed substantial growth, and the CAGR of market scale during 1997-2011 has reached 44% approximately. It is predicted that the global monoclonal antibody market scale will reach USD78 billion in 2012. Meanwhile, monoclonal antibody is also a key major source of blockbuster drugs. In 2011, the sales of six monoclonal antibody agents as Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Rituximab (Roche
Original Post Global and China Monoclonal Antibody Industry Report, 2013
Source Researchmoz Market Research
No comments:
Post a Comment